Stewart Fisher, Chief Scientific Officer at C4 Therapeutics, Inc. (CCCC), sold 34,114 shares at $45.01 ($1.5M) on 2021-08-03, disclosed to the SEC on 2021-08-05.
Open-market sale of $1.5M CCCC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 17,057 | $768K | 50.0% |
| 2 | $45.01 | 17,057 | $768K | 50.0% |
| Total | $45.01 avg | 34,114 | $1.5M | 100% |